Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Other Non Operating Income: 2020-2025

Historic Other Non Operating Income for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Sep 2025 value amounting to $223,000.

  • Insight Molecular Diagnostics' Other Non Operating Income rose 320.75% to $223,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $651,000, marking a year-over-year increase of 11.28%. This contributed to the annual value of $462,000 for FY2024, which is 17.26% up from last year.
  • According to the latest figures from Q3 2025, Insight Molecular Diagnostics' Other Non Operating Income is $223,000, which was up 78.40% from $125,000 recorded in Q2 2025.
  • In the past 5 years, Insight Molecular Diagnostics' Other Non Operating Income registered a high of $1.1 million during Q2 2021, and its lowest value of -$371,000 during Q4 2022.
  • For the 3-year period, Insight Molecular Diagnostics' Other Non Operating Income averaged around $123,727, with its median value being $127,000 (2023).
  • Its Other Non Operating Income has fluctuated over the past 5 years, first slumped by 1,900.00% in 2022, then soared by 15,400.00% in 2024.
  • Quarterly analysis of 5 years shows Insight Molecular Diagnostics' Other Non Operating Income stood at -$8,000 in 2021, then surged by 875.00% to -$371,000 in 2022, then skyrocketed by 172.51% to $269,000 in 2023, then crashed by 45.72% to $146,000 in 2024, then surged by 320.75% to $223,000 in 2025.
  • Its Other Non Operating Income stands at $223,000 for Q3 2025, versus $125,000 for Q2 2025 and $157,000 for Q1 2025.